Chemed (CHE) Misses Q3 EPS by 3c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $548.64 +2.81%
Financial Fact:
Service revenues and sales: 392.61M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Service revenues and sales: 392.61M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Chemed (NYSE: CHE) reported Q3 EPS of $1.48, $0.03 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $358.4 million versus the consensus estimate of $360 million.
Chemed sees FY2014 EPS of $6.00-$6.05, versus the consensus of $5.95.
For earnings history and earnings-related data on Chemed (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chime Financial, Inc. (CHYM) Tops Q3 EPS by 13c ; Offers Guidance
- MKS Instruments (MKSI) Tops Q3 EPS by 55c, Beats on Revenue; Offers Q4 Guidance
- Dave Inc. (DAVE) Tops Q3 EPS by 31c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
